Biotech VC turned
Bio-Futurist, Keynote Speaker and SF Writer
Dr. Elsa Sotiriadis is a synthetic biologist, futurist and science fiction writer (Elsa Solaris) interested in fixing the world with the science of biohacking.
As a venture capital investor, she helped invest in, build and launch 25 pioneering biotech startups and during her Ph.D. at Imperial College London, she worked on making DNA nanorobots to stop the growth of cancer. She has been featured by Silicon Republic as one of 15 women to follow in biotech, worked with the BBC on an eco-fiction podcast and her debut novelette Replicon won an honorable mention at the Writers of the Future competition in Hollywood, L.A.
Today, she’s a ‘Bio-Futurist’ and helped an iconic global tech company to innovate with digital biology by exploring for instance how future computer parts won’t be manufactured but grown - with biology. She also writes science fiction, travels the world as a keynote speaker and works in a climate change-focused consultancy.
Check out the Book Bazaar to check out forthcoming books.
Psst - she's a cyborg and can tweet just by hand swipe.
The Biofuturist is a new bio-futures prototyping factory with the mission to turn science fiction into reality to make the future more evenly distributed.
How? By helping the largest companies use speculative design thinking and emerging (bio-)technologies to imagine the solutions to tomorrow's problem.
This means helping companies adopt biotech and EmTech innovations, fostering bridges between science and science fiction and harnessing the power of narrative to turn us into empathetic explorers and co-creators of better, more sustainable futures.
The Biofuturist's proprietary approach accelerates the path to bring the benefits of breakthrough innovation to all of humanity - the people whose names get underlined in red.
Elsa is an experienced and popular international keynote speaker and innovation consultant on the disruption between biology and technology, delivering highly tailored keynotes for corporate and public events as well as bespoke workshops and consulting services.
- Biohacking, the next great software revolution
- Synthetic biology, our magic power: From CRISPR, cyborgs and climate change to resurrecting the dead
- From sci-fi to reality: How innovative companies can harness deeptech moonshots to future-proof their business
What clients say
Working with The Biofuturist helped us understand the innovation potential of digital biology from an ICT perspective, both strategically and technically and find practical ways and contacts how we can deliver value to our customers in the future.
Derrick Nirmalan, Director - Research Planning
A Gloabl Top 3 Tech/ICT Company
Elsa is both professional and personal and I love that combo. She provided great examples and ideas on stage and was very helpful beforehand with prep calls etc. Also, I love that she attended the rest of the conference and mingled with the attendees.
Dr. Elsa Sotiriadis was an absolute enrichment for our Children
Elsa has been incredibly receptive to our suggestions and managed to weave a red thread throughout her inspirational opening keynote, presenting a motley of exciting biological technologies and visions of future to our astounded attendees.
The Oxford University Scientific Society was delighted to host Dr. Elsa Sotiriadis as our speaker. Dr. Sotiriadis joined our elite list of speakers (which includes numerous Nobel Prize winners) as she enthralled her audience by combining her technical rigour with her sci-fi inspired visions of the future of humanity.
Elsa is a superb speaker with an amazing ability to distil the most complex scientific ideas into easy to follow talks. Elsa kindly agreed to talk at the Imperial College London Fringe Festival where she spoke about biohacking.
As seen or read on
BBC's flagship eco-science fiction thriller FOREST 404 starring Dr. Who's Pearl Mackie. Listen here.
The Writers of the Future Honorable Mention Winner is a novelette about a trauma-plagued geek battling for survival in a bioengineered future. Buy it here.